Research
Aspirin and Cancer Update
Can aspirin stop the spread of cancer? Latest update.
Read MoreChemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension
Chemomab – latest results from the Open Label Extension of the SPRING clinical trial
Read MoreLetters of Intent for Research Grants Deadline Extended
PSC Support is inviting applications (letters of intent initially) for research funding proposals. Deadline extended to 01 May
Read MoreQuality of Life in PSC Study Recruiting Now
Recruiting now
Read MoreFebruary 2025 Research Roundup
Read a research update from Martine Walmsley for February 2025.
Read MoreNew Phase 3 Trial Planned for Nebokitug in PSC
A new trial is planned for PSC
Read MoreSPRING Clinical Trial Update
Clinical Data from Phase 2 SPRING Trial Shows CM-101 Demonstrated Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Activity across Multiple Components of PSC.
Read MorePromising Preclinical Data from Rectify Pharma
Rectify Pharma presented promising preclinical data for RTY-694, their lead candidate for treating primary sclerosing cholangitis and other hepatobiliary diseases, at the 75th Annual Liver Meeting® 2024.
Read MoreIs the Asp-PSC Study Open Near You?
Sign up for an alert when the Asp-PSC Study is recruiting near you.
Read MoreNGM Bio Announces Plans for a New Clinical Trial
NGM Bio has announced plans for a new clinical trial to evaluate a medicine called aldafermin in PSC.
Read More